ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 30 filers reported holding ALBIREO PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $406,000 | -18.8% | 20,300 | +31.0% | 0.07% | -21.7% |
| Q2 2019 | $500,000 | +8.9% | 15,500 | +8.8% | 0.09% | +9.5% |
| Q1 2019 | $459,000 | +54.5% | 14,250 | +17.8% | 0.08% | +35.5% |
| Q4 2018 | $297,000 | -31.2% | 12,100 | -7.6% | 0.06% | -17.3% |
| Q3 2018 | $432,000 | -9.2% | 13,100 | -2.2% | 0.08% | -12.8% |
| Q2 2018 | $476,000 | +44.7% | 13,400 | +32.7% | 0.09% | +38.7% |
| Q1 2018 | $329,000 | +36.5% | 10,100 | +7.4% | 0.06% | +37.8% |
| Q4 2017 | $241,000 | -24.2% | 9,400 | -38.2% | 0.04% | -27.4% |
| Q3 2017 | $318,000 | +1.6% | 15,200 | 0.0% | 0.06% | -4.6% |
| Q2 2017 | $313,000 | – | 15,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |